Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 12
2005 13
2006 9
2007 11
2008 10
2009 14
2010 19
2011 22
2012 18
2013 19
2014 27
2015 17
2016 16
2017 13
2018 11
2019 6
2020 5
Text availability
Article attribute
Article type
Publication date

Cited In for PMID: 11391523

228 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.
Margusino-Framiñán L, Cid-Silva P, Rotea-Salvo S, Mena-de-Cea Á, Suárez-López F, Vázquez-Rodríguez P, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Eur J Hosp Pharm. 2020 Mar;27(e1):e41-e47. doi: 10.1136/ejhpharm-2019-002060. Epub 2020 Feb 7. Eur J Hosp Pharm. 2020. PMID: 32296504
Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver.
d'Avigdor WMH, Budzinska MA, Lee M, Lam R, Kench J, Stapelberg M, McLennan SV, Farrell G, George J, McCaughan GW, Tu T, Shackel NA. d'Avigdor WMH, et al. Sci Rep. 2019 Jul 22;9(1):10596. doi: 10.1038/s41598-019-46664-0. Sci Rep. 2019. PMID: 31332246 Free PMC article.
Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients. Results in real clinical practice.
Margusino-Framiñán L, Cid-Silva P, Mena-de-Cea A, Rodríguez-Osorio I, Pernas-Souto B, Delgado-Blanco M, Pertega-Díaz S, Martín-Herranz I, Castro-Iglesias A. Margusino-Framiñán L, et al. Rev Esp Quimioter. 2019 Apr;32(2):137-144. Epub 2019 Feb 12. Rev Esp Quimioter. 2019. PMID: 30761823 Free PMC article. Clinical Trial.
228 results
Jump to page
Feedback